CD79A and COVID-19: Lastly, emerging kinetic analyses of antibody responses following COVID-19 reveal early, near-simultaneous production of IgM, IgA, and IgG (Iyer et al., 2020), with subsequent decline of systemic IgM and IgA (Iyer et al., 2020; Sun et al., 2020).